---
schema_version: "secwatch.filing_event.v1"
accession: "0001472375-26-000113"
form_type: "8-K"
ticker: "RGPX"
cik: "0001357878"
company_name: "REGENEREX PHARMA, INC."
filed_at: "2026-04-02T23:59:59+00:00"
generated_at: "2026-05-15T07:49:11.594565+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Regenerex Pharma suspends CFO Kenneth Perry; appoints Don E. Ray as interim CFO

## Summary
- CFO Kenneth Perry placed on administrative suspension leave with pay, effective March 31, 2026, due to concerns over compliance, financial oversight, governance, and internal controls.
- Don E. Ray appointed Interim CFO effective April 1, 2026, for an initial 90-day term at an annual salary of $150,000.
- Board reassigned Perry's duties to interim CFO; review of the concerns is ongoing with no final determinations yet.

## SEC filing metadata
- accession: 0001472375-26-000113
- form_type: 8-K
- ticker: RGPX
- cik: 0001357878
- company_name: REGENEREX PHARMA, INC.
- filed_at: 2026-04-02T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357878/000147237526000113/0001472375-26-000113-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357878/000147237526000113/ixform8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001472375-26-000113
- JSON: https://secwatch.observer/filing/0001472375-26-000113.json
- Plain text: https://secwatch.observer/filing/0001472375-26-000113.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.